Advice
following an abbreviated submission
latanoprost preservative-free eye-drops (Monopost®) are accepted for restricted use within NHS Scotland.
Indication under review: for the reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension.
SMC restriction: to use in patients who have proven sensitivity to the preservative benzalkonium chloride.
SMC has previously accepted preserved latanoprost eye-drops for use in NHS Scotland. This preparation is substantially more expensive than the equivalent generic multi-dose eye drop preparation with preservative.
Download detailed advice78KB (PDF)
Medicine details
- Medicine name:
- latanoprost (Monopost)
- SMC ID:
- 879/13
- Indication:
- For the reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension.
- Pharmaceutical company
- Spectrum Thea Pharmaceuticals Limited
- BNF chapter
- Eye
- Submission type
- Abbreviated
- Status
- Restricted
- Date advice published
- 08 July 2013